|
Volumn 10, Issue 4, 2003, Pages 183-185
|
Canadian Thoracic Society COPD guidelines: Summary of highlights for family doctors
a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
BRONCHODILATING AGENT;
CEPHALOSPORIN DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID DERIVATIVE;
COTRIMOXAZOLE;
DOXYCYCLINE;
FORMOTEROL;
INFLUENZA VACCINE;
MACROLIDE;
METHYLXANTHINE;
OXYGEN;
PNEUMOCOCCUS VACCINE;
PREDNISOLONE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SALMETEROL;
THEOPHYLLINE;
TIOTROPIUM BROMIDE;
ARTICLE;
ARTIFICIAL VENTILATION;
CANADA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CIGARETTE SMOKING;
DISEASE CLASSIFICATION;
DISEASE EXACERBATION;
DISEASE SEVERITY;
EARLY DIAGNOSIS;
GENERAL PRACTITIONER;
HAEMOPHILUS INFLUENZAE;
HUMAN;
KLEBSIELLA;
MEDICAL ASSESSMENT;
MEDICAL SOCIETY;
MEDICAL SPECIALIST;
MORAXELLA CATARRHALIS;
MORBIDITY;
MORTALITY;
PATIENT CARE;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK ASSESSMENT;
SIDE EFFECT;
SMOKING CESSATION;
SMOKING HABIT;
SPIROMETRY;
SYMPTOMATOLOGY;
|
EID: 0041695171
PISSN: 11982241
EISSN: None
Source Type: Journal
DOI: 10.1155/2003/861521 Document Type: Article |
Times cited : (4)
|
References (1)
|